Shareholders meeting
- Deep proprietary digital map data and API ecosystem with strong moats in automotive OEM navigation and enterprise workflows
- Large executable order book of ₹1,750 Cr (~3.7x TTM revenue) providing multi-year visibility across ADAS, drones, and railways
- Clean capital structure with ₹931 Cr net worth, negligible debt (₹7 Cr), and healthy 22% ROCE
- Strong sequential rebound in Q4 FY26 (revenue ₹145 Cr, EBITDA margin 44.6%) indicating pricing resilience after mid-year lumpiness
- Announcement is purely routine: order book and dividend were already fully disclosed in May 2026 filings
- High trailing P/E of 47.9x versus peer median of 25.7x leaves limited margin of safety for execution delays
- Revenue lumpiness and margin dilution risk when product mix shifts towards hardware-heavy IoT and outsourced government implementations
- International JV (Southeast Asia) remains in an investment loss phase, temporarily dampening consolidated net margins
C.E. Info Systems (MapmyIndia) - Research Note (As of July 18, 2026)
1. Announcement Context & Freshness Assessment
The announcement issued on July 18, 2026, concerns the dispatch of the FY2025-26 Annual Report and notice for the 31st AGM. The reported items—a ₹1,750 Cr executable order book/pipeline visibility, ₹3.50 final dividend, and Rohan Verma's elevation to Joint MD—are reiterative disclosures already published during the Q4 FY26 financial results in May 2026 and board outcomes in June 2026. Consequently, already_priced_in is TRUE, and the direct news impact score is low (20/100).
2. Ramp-Aware Execution & Financial Math
- Backlog Sizing: ₹1,750 Cr pipeline vs. TTM revenue of ₹474 Cr (~3.7x).
- Realistic Delivery Horizon: Enterprise API, automotive ADAS, drone, and government contracts typically convert over a 3 to 4-year cycle (average: 3.5 years).
- Annualized Execution: Incremental recognized revenue will ramp from ~₹100–120 Cr in Year 1 to ~₹200–250 Cr per year at steady state.
- Margin Profile: Map-led high-margin software delivers ~38-42% OPM, whereas IoT integration and government sub-contracting drop OPM to ~25-30%. Blended steady-state OPM is modelled at ~36-38%, with PAT margins around 28-30%.
- Earnings Progression:
- TTM (FY26): Revenue ₹474 Cr | PAT ₹134 Cr | EPS ₹24.50
- FY27 (Year 1 ramp): Projected Revenue ~₹580 Cr (+22.4%) | PAT ~₹168 Cr | EPS ~₹30.70
- FY28/FY29 (Steady State): Target Revenue ~₹780–850 Cr | PAT ~₹235–255 Cr | EPS ~₹43.00–46.70 (+75% to +90% over TTM).
3. Industry Dynamics & Moat Quality
- Capital Intensity: LOW. Software development and geospatial IP have high upfront fixed costs but virtually zero incremental marginal cost once deployed.
- Execution Difficulty: MEDIUM. Pure-play digital map licensing scales seamlessly, but customized enterprise deployments and IoT fleet solutions require technical integration and working capital management.
- Structural Moat: Proprietary street-level Indian mapping data, partnerships with automotive OEMs, and high API switching costs for delivery/logistics applications create a durable competitive advantage.
4. Scenario Analysis & Valuation
-
Current Stock Price: ₹1,173.0 (Market Cap: ₹6,420 Cr, Trailing P/E: 47.9x).
-
Bull Case (75% upside / Target ₹2,050):
- FY28 Revenue reaches ₹950 Cr on accelerated ADAS adoption and successful international JV scale-up.
- PAT margin expands to 32% (PAT ₹304 Cr, EPS ~₹55.50).
-
Exit P/E settles at a premium 37.0x.
-
Base Case (35% upside / Target ₹1,580):
- Order book converts over 3.5-4 years; FY28 Revenue hits ₹760 Cr with PAT margin of 28% (PAT ₹213 Cr, EPS ~₹39.00).
-
Exit P/E moderates to ~40.5x on steady 20%+ compound growth.
-
Bear Case (-24% downside / Target ₹890):
- Conversion delays in government/railway contracts; margin compression from hardware/IoT mix (PAT margin falls to 22%).
- FY28 PAT stagnates around ₹145 Cr (EPS ~₹26.50); valuation de-rates towards peer median (P/E ~33x).
5. Verdict Rationale
MapmyIndia is an exceptional deep-tech platform business with strong unit economics (22% ROCE, debt-free, 35%+ OPM). However, because the ₹1,750 Cr order pipeline was already fully digested by the market two months prior, and the company trades at an elevated 48x trailing P/E following a transitional FY26 (2.4% full-year top-line growth), the stock qualifies as a POSSIBLE multibagger candidate requiring patient execution monitoring rather than an immediate catalyst-driven breakout.
